FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587092505> ?p ?o ?g. }

• W2587092505 abstract "Abstract Abstract 321 Background: Multiple myeloma (MM) is characterized by the presence of monoclonal protein (M-protein) in serum and/or urine, clonal plasma cell accumulation in bone marrow (BM), and related organ or tissue impairment. MM patients are monitored during therapy and posttherapy using immunoglobulin, M-protein and free light chain assays. Assessing pathological myeloma cells using flow cytometry and RT-PCR has been shown to have superior prognostic value. However, the sensitivity of these techniques has generally limited their use to assessment of BM. In order to determine whether myeloma minimal residual disease could be detected in peripheral blood (PB), we assessed a cohort of MM patients using a sequencing based platform, LymphoSIGHT, with a sensitivity of 1 cancer cell per million leukocytes. Methods: We obtained from 4 sources (UCSF, NYU, Washington Univ, commercial source) pairs of BM and PB samples from 60 MM patients at different points of disease. BM samples were used to identify the clonal MM sequence and detection of that sequence in the PB was assessed. For some patients BM/PB sample pairs were obtained from >1 time point resulting in a total of 78 pairs. In addition blood and bone marrow plasma samples were available for 44 and 6 patients, respectively, to assess presence of the myeloma clonotype in cell free DNA. Altogether there were 206 samples. BM samples were either available as BM mononuclear cells (BMMC) or bead enriched CD138+ cells. Using universal primer sets, we amplified IgH@ variable (V), diversity (D), and joining (J) gene segments from genomic DNA and/or RNA samples, the incomplete IgH rearrangement (DJ), and IgK from genomic DNA. Amplified products were sequenced to obtain >1 million reads and analyzed using standardized algorithms for clonotype determination. Myeloma-specific IgH, IgK, and DJ clonotypes were identified for each patient based on their high frequency in BM samples. The presence of the myeloma clonotype was then assessed in all PBMC (DNA and RNA), BM plasma (DNA), and PB plasma (DNA) samples using the same IgH and in some samples using the IgK sequencing assays. A quantitative and standardized measure of clone level among all leukocytes in each PB or BM sample was determined using internal reference DNA. Here we describe data on 46/60 patients; data from all 60 patients will be presented. Results: In BM samples, we detected the myeloma clonal rearrangement of at least one receptor (“calibrating receptor”) in 34/46 (74%) of MM patients (Table 1). The calibration rate varied by receptor, with 30/46 (65%) patients calibrating with IgH, 14/43 (33%) with IgH DJ, and 22/43 (51%) with IgK (Table 1). Identification of myeloma-specific clonal rearrangement is based on presence at high frequency and may not occur in samples from patients with low disease load (e.g., post-treatment). Of the 12 non-calibrating patients, only 3 had high disease load. The myeloma clonotype that was identified in the BM was also detected in PBMC in 22/30 (73%) and 28/30 (93%) patients with the DNA and RNA IgH analysis, respectively (Table 2). IgK DNA analysis showed the presence of the myeloma clonotype in 9/10 PBMC samples, all of which were concordant with IgH results. The myeloma clonotype that was identified in the BM was also detected in the cell-free BM and PB samples in 5/5 and 7/11 patients, respectively, using the IgH DNA assay. The evaluation of blood plasma and PBMC were at times complementary in detecting the myeloma. Conclusions: Results from the application of a high-throughput sequencing method for detection of myeloma-specific clonotypes in 46 MM patients are shown. A clonal rearrangement was detected in 74% of MM BM samples. Importantly, 93% of peripheral blood samples from 30 patients showed evidence of circulating myeloma in PBMC. Analysis of BM and PB samples from 14 additional MM patients as well as association of the level of myeloma in PBMC and BM with clinical measures is ongoing. Disclosures: Faham: Sequenta, Inc.: Employment, Equity Ownership, Research Funding. Klinger:Sequenta, Inc.: Employment, Equity Ownership, Research Funding." @default.
• W2587092505 created "2017-02-17" @default.
• W2587092505 creator A5002571777 @default.
• W2587092505 creator A5011954777 @default.
• W2587092505 creator A5014513613 @default.
• W2587092505 creator A5021003906 @default.
• W2587092505 creator A5022565348 @default.
• W2587092505 creator A5026151069 @default.
• W2587092505 creator A5032212629 @default.
• W2587092505 creator A5077169512 @default.
• W2587092505 date "2012-11-16" @default.
• W2587092505 modified "2023-09-27" @default.
• W2587092505 title "Detection of Multiple Myeloma Cells in Peripheral Blood Using High-Throughput Sequencing Assay" @default.
• W2587092505 doi "https://doi.org/10.1182/blood.v120.21.321.321" @default.
• W2587092505 hasPublicationYear "2012" @default.
• W2587092505 type Work @default.
• W2587092505 sameAs 2587092505 @default.
• W2587092505 citedByCount "0" @default.
• W2587092505 crossrefType "journal-article" @default.
• W2587092505 hasAuthorship W2587092505A5002571777 @default.
• W2587092505 hasAuthorship W2587092505A5011954777 @default.
• W2587092505 hasAuthorship W2587092505A5014513613 @default.
• W2587092505 hasAuthorship W2587092505A5021003906 @default.
• W2587092505 hasAuthorship W2587092505A5022565348 @default.
• W2587092505 hasAuthorship W2587092505A5026151069 @default.
• W2587092505 hasAuthorship W2587092505A5032212629 @default.
• W2587092505 hasAuthorship W2587092505A5077169512 @default.
• W2587092505 hasConcept C137061746 @default.
• W2587092505 hasConcept C142724271 @default.
• W2587092505 hasConcept C153911025 @default.
• W2587092505 hasConcept C159654299 @default.
• W2587092505 hasConcept C163864487 @default.
• W2587092505 hasConcept C202751555 @default.
• W2587092505 hasConcept C203014093 @default.
• W2587092505 hasConcept C2776364478 @default.
• W2587092505 hasConcept C2776396001 @default.
• W2587092505 hasConcept C2779823535 @default.
• W2587092505 hasConcept C2780007613 @default.
• W2587092505 hasConcept C36394416 @default.
• W2587092505 hasConcept C542903549 @default.
• W2587092505 hasConcept C55493867 @default.
• W2587092505 hasConcept C71924100 @default.
• W2587092505 hasConcept C86803240 @default.
• W2587092505 hasConceptScore W2587092505C137061746 @default.
• W2587092505 hasConceptScore W2587092505C142724271 @default.
• W2587092505 hasConceptScore W2587092505C153911025 @default.
• W2587092505 hasConceptScore W2587092505C159654299 @default.
• W2587092505 hasConceptScore W2587092505C163864487 @default.
• W2587092505 hasConceptScore W2587092505C202751555 @default.
• W2587092505 hasConceptScore W2587092505C203014093 @default.
• W2587092505 hasConceptScore W2587092505C2776364478 @default.
• W2587092505 hasConceptScore W2587092505C2776396001 @default.
• W2587092505 hasConceptScore W2587092505C2779823535 @default.
• W2587092505 hasConceptScore W2587092505C2780007613 @default.
• W2587092505 hasConceptScore W2587092505C36394416 @default.
• W2587092505 hasConceptScore W2587092505C542903549 @default.
• W2587092505 hasConceptScore W2587092505C55493867 @default.
• W2587092505 hasConceptScore W2587092505C71924100 @default.
• W2587092505 hasConceptScore W2587092505C86803240 @default.
• W2587092505 hasLocation W25870925051 @default.
• W2587092505 hasOpenAccess W2587092505 @default.
• W2587092505 hasPrimaryLocation W25870925051 @default.
• W2587092505 hasRelatedWork W11718440 @default.
• W2587092505 hasRelatedWork W2064513556 @default.
• W2587092505 hasRelatedWork W2136898525 @default.
• W2587092505 hasRelatedWork W2306410245 @default.
• W2587092505 hasRelatedWork W2342078474 @default.
• W2587092505 hasRelatedWork W2530127268 @default.
• W2587092505 hasRelatedWork W2553582962 @default.
• W2587092505 hasRelatedWork W2560892066 @default.
• W2587092505 hasRelatedWork W2594074801 @default.
• W2587092505 hasRelatedWork W2604863626 @default.
• W2587092505 hasRelatedWork W2613849585 @default.
• W2587092505 hasRelatedWork W2888853713 @default.
• W2587092505 hasRelatedWork W2909451113 @default.
• W2587092505 hasRelatedWork W2979421844 @default.
• W2587092505 hasRelatedWork W2981223144 @default.
• W2587092505 hasRelatedWork W2991321296 @default.
• W2587092505 hasRelatedWork W3213075452 @default.
• W2587092505 hasRelatedWork W5135189 @default.
• W2587092505 hasRelatedWork W567351695 @default.
• W2587092505 hasRelatedWork W84633733 @default.
• W2587092505 isParatext "false" @default.
• W2587092505 isRetracted "false" @default.
• W2587092505 magId "2587092505" @default.
• W2587092505 workType "article" @default.